JAZZ PHARMACEUTICALS FRANCE

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 2003-01-01

Employees: -

Market Cap: -

Website: https://www.jazzpharma.com/careers/open-positions/

Clinical Trials

Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

Phase 3

Completed

Conditions: Hepatic Veno-Occlusive Disease

Interventions: Drug: Defibrotide

First Posted Date: 2008-03-05

Last Posted Date: 2017-11-30

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 1206

Registration Number: NCT00628498

Locations: 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
University of Maryland - Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

and more 122 locations

Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

Phase 2

Completed

Conditions: Essential Tremor

Interventions: Other: Placebo
Drug: Sodium Oxybate

First Posted Date: 2008-01-18

Last Posted Date: 2012-01-23

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 19

Registration Number: NCT00598078

Locations: 🇺🇸
Quest Research Institiute, Bingham Farms, Michigan, United States

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Phase 2

Completed

Conditions: Epilepsy

Interventions: Drug: Clonazepam

First Posted Date: 2008-01-16

Last Posted Date: 2014-07-01

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 45

Registration Number: NCT00594945

Locations: 🇺🇸
Clinical Trials. inc., Little Rock, Arkansas, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Columbia Comprehensive Epilepsy Center, Neurological Institute, New York, New York, United States

and more 3 locations

Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.

Phase 3

Completed

Conditions: Fibromyalgia

Interventions: Drug: Xyrem®

First Posted Date: 2007-01-18

Last Posted Date: 2012-03-30

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 560

Registration Number: NCT00423605

Locations: 🇺🇸
Fibromyalgia Treatment Centers of America, Chicago, Illinois, United States
🇺🇸
Center for Arthiritis and Rheumatism, Vero Beach, Florida, United States
🇺🇸
Graves - Gilbert Clinic, Bowling Green, Kentucky, United States

and more 88 locations

A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.

Phase 3

Completed

Conditions: Fibromyalgia

Interventions: Drug: Xyrem®
Drug: placebo

First Posted Date: 2007-01-18

Last Posted Date: 2012-01-24

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 573

Registration Number: NCT00423813

Locations: 🇺🇸
Drug Studies America, Marietta, Georgia, United States
🇺🇸
Louisiana Sleep Foundation, Baton Rouge, Louisiana, United States
🇺🇸
Medex Healthcare Research, Inc, St. louis, Missouri, United States

and more 112 locations

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Phase 1

Completed

Conditions: Hematologic Neoplasms

First Posted Date: 2006-10-18

Last Posted Date: 2012-05-17

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 48

Registration Number: NCT00389428

Locations: 🇺🇸
H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida, Tampa, Florida, United States
🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
North Shore University Hospital, Manhasset, New York, United States

and more 1 locations

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

Phase 3

Completed

Conditions: Fibromyalgia

Interventions: Drug: Placebo
Drug: Xyrem®

First Posted Date: 2006-09-01

Last Posted Date: 2011-12-29

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 548

Registration Number: NCT00371137

Locations: 🇺🇸
Clinical Pharmacology Study Group, Worcester, Massachusetts, United States
🇺🇸
AAIR Research Center, Rochester, New York, United States
🇺🇸
Wake Research Associates, LLC, Raleigh, North Carolina, United States

and more 66 locations

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Neoplasms

First Posted Date: 2006-08-09

Last Posted Date: 2021-07-02

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 65

Registration Number: NCT00361842

Locations: 🇺🇸
California Cancer Center, Greenbrae, California, United States
🇺🇸
Lombardi Comprehensive Cancer Research Institute, Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
Broward Oncology Associates, Fort Lauderdale, Florida, United States

and more 9 locations

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Phase 3

Completed

Conditions: Severe Hepatic Veno-Occlusive Disease

Interventions: Drug: Defibrotide

First Posted Date: 2006-08-01

Last Posted Date: 2017-01-30

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 134

Registration Number: NCT00358501

Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy

Phase 3

Completed

Conditions: Narcolepsy

First Posted Date: 2005-08-22

Last Posted Date: 2013-11-25

Lead Sponsor: Jazz Pharmaceuticals

Target Recruit Count: 59

Registration Number: NCT00132873

Locations: 🇨🇦
Brain and Sleep Diagnostic Centre, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy